BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 25520612)

  • 1. "You Shall Not Pass"-tight junctions of the blood brain barrier.
    Bauer HC; Krizbai IA; Bauer H; Traweger A
    Front Neurosci; 2014; 8():392. PubMed ID: 25520612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight Junctions of the Blood-Brain Barrier - A Molecular Gatekeeper.
    Bauer H; Traweger A
    CNS Neurol Disord Drug Targets; 2016; 15(9):1016-1029. PubMed ID: 27633783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.
    Redzic Z
    Fluids Barriers CNS; 2011 Jan; 8(1):3. PubMed ID: 21349151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases.
    Khalil A; Barras A; Boukherroub R; Tseng CL; Devos D; Burnouf T; Neuhaus W; Szunerits S
    Nanoscale Horiz; 2023 Dec; 9(1):14-43. PubMed ID: 37853828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold Nanoparticles Increase Endothelial Paracellular Permeability by Altering Components of Endothelial Tight Junctions, and Increase Blood-Brain Barrier Permeability in Mice.
    Li CH; Shyu MK; Jhan C; Cheng YW; Tsai CH; Liu CW; Lee CC; Chen RM; Kang JJ
    Toxicol Sci; 2015 Nov; 148(1):192-203. PubMed ID: 26272951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.
    Lochhead JJ; Ronaldson PT; Davis TP
    AAPS J; 2017 Jul; 19(4):910-920. PubMed ID: 28353217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro models of the blood-brain barrier.
    Czupalla CJ; Liebner S; Devraj K
    Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight junctions.
    Balda MS; Matter K
    Curr Biol; 2023 Nov; 33(21):R1135-R1140. PubMed ID: 37935122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
    Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
    Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.
    Luissint AC; Artus C; Glacial F; Ganeshamoorthy K; Couraud PO
    Fluids Barriers CNS; 2012 Nov; 9(1):23. PubMed ID: 23140302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-12 is not required for blood-brain barrier tight junction function.
    Castro Dias M; Coisne C; Baden P; Enzmann G; Garrett L; Becker L; Hölter SM; ; Hrabě de Angelis M; Deutsch U; Engelhardt B
    Fluids Barriers CNS; 2019 Sep; 16(1):30. PubMed ID: 31511021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junctions in brain barriers during central nervous system inflammation.
    Coisne C; Engelhardt B
    Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier tight junction permeability and ischemic stroke.
    Sandoval KE; Witt KA
    Neurobiol Dis; 2008 Nov; 32(2):200-19. PubMed ID: 18790057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.
    Al-Obaidi MMJ; Desa MNM
    Cell Mol Neurobiol; 2018 Oct; 38(7):1349-1368. PubMed ID: 30117097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
    Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
    Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight Junction Modulating Bioprobes for Drug Delivery System to the Brain: A Review.
    Tachibana K; Iwashita Y; Wakayama E; Nishino I; Nishikaji T; Kondoh M
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33352631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain barriers: Crosstalk between complex tight junctions and adherens junctions.
    Tietz S; Engelhardt B
    J Cell Biol; 2015 May; 209(4):493-506. PubMed ID: 26008742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight junction modulators for drug delivery to the central nervous system.
    Hashimoto Y; Tachibana K; Kondoh M
    Drug Discov Today; 2020 Aug; 25(8):1477-1486. PubMed ID: 32439607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.